Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - INTEREST INCOME & EXPENSE
Interest Income & Expense FOLD - Amicus Therapeutics, Inc.
50.1 M
LAST VALUE
24.27%
2 YEAR CAGR
17.49%
5 YEAR CAGR
101.26%
10 YEAR CAGR